DDX54 Antibody - BSA Free
Novus Biologicals | Catalog # NB100-60678
Scientific images may be resized, cropped, or adjusted for brightness or contrast for presentation purposes. These updates are limited to presentation and do not affect the underlying scientific interpretation of the data. Where available, additional source data may be provided upon request.
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Format
Product Specifications
Immunogen
Reactivity Notes
Clonality
Host
Isotype
Scientific Data Images for DDX54 Antibody - BSA Free
Immunoprecipitation: DDX54 Antibody [NB100-60678]
Immunoprecipitation: DDX54 Antibody [NB100-60678] - Detection of Human DDX54 on HeLa whole cell lysate using NB100-60678. DDX54 was also immunoprecipitated by rabbit anti-DDX54 antibody NB100-60677.Western Blot: DDX54 Antibody - BSA Free [NB100-60678] -
An shRNA targeting DDX54 causes activation of PKR. (a) Representative immunoblot of pPKR and other proteins of interest following knockdown of DDX54 by shDDX54-4 and shDDX54-5 (identical shRNA sequence) in MDA-MB-231 and BT549. Total protein was imaged using a Stain-Free Gel and was used for normalization. (b) Quantification of pPKR/PKR from the immunoblot in (a). See Supplemental Fig. 1 for quantification of other proteins of interest. (c) Quantification of foci formation shown in (d). (e) Representative immunoblot of pPKR and other proteins of interest following knockdown of DDX54 by shDDX54-4 in empty vector (EV) control MDA-MB-231 or DDX54 overexpressing (DDX54-OE) MDA-MB-231. (f) Cell proliferation as measured by counting viable cells by trypan blue exclusion. (g) Quantification of immunoblot in (e). (h) Representative immunoblot of pPKR and other proteins of interest following knockdown of DDX54 by shDDX54-4 in empty vector (EV) control BT549 or DDX54 overexpressing (DDX54-OE) BT549. (i) Quantification of immunoblot in (h). Bars or larger points represent the average of at least three replicates (shown as differently shaped points), error bars are +/- SD. *p < 0.05, **p < 0.01, ***p < 0.001. P-values determined by Dunnett’s test (b,c) or one-way ANOVA with post-hoc Tukey (g–i). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39384561), licensed under a CC-BY license. Not internally tested by Novus Biologicals.Western Blot: DDX54 Antibody - BSA Free [NB100-60678] -
An shRNA targeting DDX54 causes activation of PKR. (a) Representative immunoblot of pPKR and other proteins of interest following knockdown of DDX54 by shDDX54-4 and shDDX54-5 (identical shRNA sequence) in MDA-MB-231 and BT549. Total protein was imaged using a Stain-Free Gel and was used for normalization. (b) Quantification of pPKR/PKR from the immunoblot in (a). See Supplemental Fig. 1 for quantification of other proteins of interest. (c) Quantification of foci formation shown in (d). (e) Representative immunoblot of pPKR and other proteins of interest following knockdown of DDX54 by shDDX54-4 in empty vector (EV) control MDA-MB-231 or DDX54 overexpressing (DDX54-OE) MDA-MB-231. (f) Cell proliferation as measured by counting viable cells by trypan blue exclusion. (g) Quantification of immunoblot in (e). (h) Representative immunoblot of pPKR and other proteins of interest following knockdown of DDX54 by shDDX54-4 in empty vector (EV) control BT549 or DDX54 overexpressing (DDX54-OE) BT549. (i) Quantification of immunoblot in (h). Bars or larger points represent the average of at least three replicates (shown as differently shaped points), error bars are +/- SD. *p < 0.05, **p < 0.01, ***p < 0.001. P-values determined by Dunnett’s test (b,c) or one-way ANOVA with post-hoc Tukey (g–i). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39384561), licensed under a CC-BY license. Not internally tested by Novus Biologicals.Western Blot: DDX54 Antibody - BSA Free [NB100-60678] -
An shRNA targeting DDX54 causes activation of PKR. (a) Representative immunoblot of pPKR and other proteins of interest following knockdown of DDX54 by shDDX54-4 and shDDX54-5 (identical shRNA sequence) in MDA-MB-231 and BT549. Total protein was imaged using a Stain-Free Gel and was used for normalization. (b) Quantification of pPKR/PKR from the immunoblot in (a). See Supplemental Fig. 1 for quantification of other proteins of interest. (c) Quantification of foci formation shown in (d). (e) Representative immunoblot of pPKR and other proteins of interest following knockdown of DDX54 by shDDX54-4 in empty vector (EV) control MDA-MB-231 or DDX54 overexpressing (DDX54-OE) MDA-MB-231. (f) Cell proliferation as measured by counting viable cells by trypan blue exclusion. (g) Quantification of immunoblot in (e). (h) Representative immunoblot of pPKR and other proteins of interest following knockdown of DDX54 by shDDX54-4 in empty vector (EV) control BT549 or DDX54 overexpressing (DDX54-OE) BT549. (i) Quantification of immunoblot in (h). Bars or larger points represent the average of at least three replicates (shown as differently shaped points), error bars are +/- SD. *p < 0.05, **p < 0.01, ***p < 0.001. P-values determined by Dunnett’s test (b,c) or one-way ANOVA with post-hoc Tukey (g–i). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39384561), licensed under a CC-BY license. Not internally tested by Novus Biologicals.Western Blot: DDX54 Antibody - BSA Free [NB100-60678] -
An shRNA targeting DDX54 causes activation of PKR. (a) Representative immunoblot of pPKR and other proteins of interest following knockdown of DDX54 by shDDX54-4 and shDDX54-5 (identical shRNA sequence) in MDA-MB-231 and BT549. Total protein was imaged using a Stain-Free Gel and was used for normalization. (b) Quantification of pPKR/PKR from the immunoblot in (a). See Supplemental Fig. 1 for quantification of other proteins of interest. (c) Quantification of foci formation shown in (d). (e) Representative immunoblot of pPKR and other proteins of interest following knockdown of DDX54 by shDDX54-4 in empty vector (EV) control MDA-MB-231 or DDX54 overexpressing (DDX54-OE) MDA-MB-231. (f) Cell proliferation as measured by counting viable cells by trypan blue exclusion. (g) Quantification of immunoblot in (e). (h) Representative immunoblot of pPKR and other proteins of interest following knockdown of DDX54 by shDDX54-4 in empty vector (EV) control BT549 or DDX54 overexpressing (DDX54-OE) BT549. (i) Quantification of immunoblot in (h). Bars or larger points represent the average of at least three replicates (shown as differently shaped points), error bars are +/- SD. *p < 0.05, **p < 0.01, ***p < 0.001. P-values determined by Dunnett’s test (b,c) or one-way ANOVA with post-hoc Tukey (g–i). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39384561), licensed under a CC-BY license. Not internally tested by Novus Biologicals.Western Blot: DDX54 Antibody - BSA Free [NB100-60678] -
Knockdown of ADAR1 enhances PKR activation in cells expressing shDDX54-4. (a) Representative immunoblot of pPKR and other proteins of interest in SKBR3 expressing shDDX54-4 or shSCR, with or without knockdown of ADAR1. Total protein was imaged using a Stain-Free Gel and was used for normalization. (b) Quantification of pPKR/PKR from the immunoblot in (a). See Supplemental Fig. 2 for quantification of other proteins of interest. (c) Quantification of foci formation shown in (d) for SK-BR-3. (a) Representative immunoblot of pPKR and other proteins of interest in MCF-7 expressing shDDX54-4 or shSCR, with or without knockdown of ADAR1. Total protein was imaged using a Stain-Free Gel and was used for normalization. (b) Quantification of pPKR/PKR from the immunoblot in (a). See Supplemental Fig. 2 for quantification of other proteins of interest. (c) Quantification of foci formation shown in (d) for MCF-7. Bars represent the average of at least three replicates (shown as differently shaped points), error bars are +/- SD. *p < 0.05, **p < 0.01, ***p < 0.001. P-values determined by one-way ANOVA with post-hoc Tukey. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/39384561), licensed under a CC-BY license. Not internally tested by Novus Biologicals.Applications for DDX54 Antibody - BSA Free
Immunoprecipitation
Formulation, Preparation, and Storage
Purification
Formulation
Format
Preservative
Concentration
Shipping
Stability & Storage
Background: DDX54
Alternate Names
Entrez Gene IDs
Gene Symbol
UniProt
Additional DDX54 Products
Product Documents for DDX54 Antibody - BSA Free
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for DDX54 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Citations for DDX54 Antibody - BSA Free
Customer Reviews for DDX54 Antibody - BSA Free
There are currently no reviews for this product. Be the first to review DDX54 Antibody - BSA Free and earn rewards!
Have you used DDX54 Antibody - BSA Free?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 for a review with an image
$10/€7/£6/$10CAN/¥1110 for a review without an image
Submit a review